Literature DB >> 10451164

A 20-year epidemiological study of pneumococcal meningitis.

R J Stanek1, M A Mufson.   

Abstract

We conducted a retrospective analysis of 55 community-acquired Streptococcus pneumoniae meningitis illnesses in Huntington, West Virginia, from 1978 to 1997. Fourteen (36.8%) of 38 adults and 2 (11.8%) of 17 children died. Serotypes 6, 23, 3, and 18 accounted for 20 (41.7%) of 48 strains available for serotyping. Of 40 strains available for antimicrobial susceptibility testing, 1 serotype 19 and 1 serotype 23 strain showed intermediate resistance and a second serotype 23 strain showed high resistance to penicillin; all three patients survived. The case-fatality rates among adults who received penicillin alone, gentamicin in combination, or vancomycin and cephalosporin together were 57.1%, 55.5%, and 60%, respectively, and among those who received chloramphenicol or a third-generation cephalosporin, they were 11.1% or nil, respectively. No child died who received chloramphenicol or vancomycin. Two (33%) of 6 children died who received a third-generation cephalosporin; both were critically ill when initially treated. No child and one adult had received pneumococcal vaccine prior to becoming ill.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451164     DOI: 10.1086/514777

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain.

Authors:  Ronald J Stanek; Mary B Maher; Nancy B Norton; Maurice A Mufson
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  Pathophysiology and treatment of bacterial meningitis.

Authors:  Olaf Hoffman; R Joerg Weber
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

4.  Treatment of Bacterial Meningitis.

Authors:  Allan R. Tunkel; W. Michael Scheld
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

5.  Epidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center.

Authors:  C Rock; C Sadlier; J Fitzgerald; M Kelleher; C Dowling; S Kelly; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-24       Impact factor: 3.267

6.  Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.

Authors:  Hisanori Domon; Tomoki Maekawa; Daisuke Yonezawa; Kosuke Nagai; Masataka Oda; Katsunori Yanagihara; Yutaka Terao
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

7.  Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.

Authors:  Jean-Louis Vincent; Simon Nadel; Demetrios J Kutsogiannis; R T Noel Gibney; S Betty Yan; Virginia L Wyss; Joan E Bailey; Carol L Mitchell; Samiha Sarwat; Stephen M Shinall; Jonathan M Janes
Journal:  Crit Care       Date:  2005-05-17       Impact factor: 9.097

8.  Fatal meningitis in a previously healthy young adult caused by Streptococcus pneumoniae serotype 38: an emerging serotype?

Authors:  Carolyn I Baker; Christopher P Barrozo; Margaret A K Ryan; Lisa A Pearse; Kevin L Russell
Journal:  BMC Infect Dis       Date:  2005-05-19       Impact factor: 3.090

9.  Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors.

Authors:  Juan M Flores-Cordero; Rosario Amaya-Villar; Maria D Rincón-Ferrari; Santiago R Leal-Noval; José Garnacho-Montero; Ana C Llanos-Rodríguez; Francisco Murillo-Cabezas
Journal:  Intensive Care Med       Date:  2003-08-06       Impact factor: 41.787

10.  Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.

Authors:  Pernille Martens; Signe Westring Worm; Bettina Lundgren; Helle Bossen Konradsen; Thomas Benfield
Journal:  BMC Infect Dis       Date:  2004-06-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.